503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.11%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-11.19%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-2.04%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
3.23%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
6.17%
R&D change of 6.17% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
13.56%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-0.45%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
84.21%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
3.88%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
-4.21%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
-6.12%
Interest expense reduction while CRWV shows 1.19% growth. Joel Greenblatt would examine advantage.
-2.65%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-5.86%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-0.55%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-6.59%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-1.57%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-168.04%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-8.82%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-3.91%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-14.16%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-7.70%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-2.73%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-7.84%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-7.28%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.25%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.21%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.